Chronic treatment with bark infusion fromCroton cajucaralowers plasma triglyceride levels in genetic hyperlipidemic mice
Authors:
- Alba R.M Souza-BritoASAlba R.M Souza-Brito
- Eliana C. de FariaEFEliana C. de Faria
- Helena C.F OliveiraHOHelena C.F Oliveira
- 1 May 2004
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 82 (6) , 387-392
Abstract
Aqueous infusion and preparations containing dehydrocrotonin (DHC) and essential oil from Croton cajucara bark were tested for plasma lipid-lowering effects in genetically modified hyperlipidemic mice. Two mouse models were tested: 1) primary hypercholesterolemia resulting from the LDL-receptor gene knockout, and 2) combined hyperlipidemia resulting from crosses of LDL-receptor knockout mice with transgenic mice overexpressing apolipo protein (apo) CIII and cholesteryl ester-transfer protein. Mice treated with bark infusion, DHC, essential oil, or placebos for 25 days showed no signals of toxicity as judged by biochemical tests for liver and kidney functions. The bark infusion reduced triglyceride plasma levels by 40%, while essential oil and DHC had no significant effects on plasma lipid levels. The bark infusion treatment promoted a redistribution of cholesterol among the lipoprotein fractions in combined hyperlipidemic mice. There was a marked reduction in the VLDL fraction and an increase in the HDL fraction, in such a way that the (VLDL + LDL)/HDL ratio was reduced by half. The bark infusion treatment did not modify cholesterol distribution in hypercholesterolemic mice. In conclusion, C. cajucara bark infusion reduced plasma triglycerides levels and promoted a redistribution of cholesterol among lipoproteins in genetically combined hyperlipidemic mice. These changes modify risk factors for the development of atherosclerotic diseases.Key words: hyperlipidemia, transgenic mice, Croton cajucara, dehydrocrotonin, cholesterol.Keywords
This publication has 32 references indexed in Scilit:
- Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic miceMetabolism, 2001
- Hypertriglyceridemia and the fibrate trialsCurrent Opinion in Lipidology, 2000
- Pinus pinaster Oil Affects Lipoprotein Metabolism in Apolipoprotein E-Deficient MiceThe Journal of Nutrition, 1999
- Health-promoting properties of common herbsThe American Journal of Clinical Nutrition, 1999
- Effects ofCroton cajucara Extract on Serum Lipids of Rats Fed A High Fat DietPhytotherapy Research, 1996
- Mouse Models of AtherosclerosisScience, 1996
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Regulation of the synthesis, processing and translocation of lipoprotein lipaseBiochemical Journal, 1992
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972